Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul;42(7):1119-1131.
doi: 10.1007/s00296-021-05035-7. Epub 2021 Oct 21.

Polymyositis and dermatomyositis: ocular manifestations and potential sight-threatening complications

Affiliations
Review

Polymyositis and dermatomyositis: ocular manifestations and potential sight-threatening complications

Raul E Ruiz-Lozano et al. Rheumatol Int. 2022 Jul.

Abstract

Dermatomyositis (DM) and polymyositis (PM) are idiopathic inflammatory myopathies characterized by progressive, symmetric, mainly proximal muscle weakness. DM is also characterized by cutaneous involvement. However, other clinical features, systemic involvement, histopathological findings, response to treatment, and prognosis, differ significantly. Although uncommon, ocular manifestations in DM and PM may potentially affect any structure within the eye. Notwithstanding being generally mild, ocular involvement in DM and PM may result in significant morbidity. Left untreated, significant retinal inflammation associated with hemorrhage and detachment may occur, leading to significant vision loss. This review aims to present an up-to-date overview for rheumatologists about the ocular involvement and potential complications of DM and PM and when to refer to the ophthalmologist to avoid sight-threatening complications.

Keywords: Anterior eye segment; Dermatomyositis; Eye manifestations; Eyelids; Polymyositis; Posterior eye segment; Retinal hemorrhage.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Vencovsky J, Alexanderson H, Lundberg IE (2019) Idiopathic inflammatory myopathies. Rheum Dis Clin N Am 45:569–581. https://doi.org/10.1016/j.rdc.2019.07.006 - DOI
    1. Findlay AR, Goyal NA, Mozaffar T (2015) An overview of polymyositis and dermatomyositis. Muscle Nerve 51:638–656. https://doi.org/10.1002/mus.24566 - DOI - PubMed
    1. Bruce GM (1938) Retinitis in dermatomyositis. Trans Am Ophthalmol Soc 36:282–297 - PubMed - PMC
    1. Hotta K (2006) Choroidopathy with serous retinal detachment in a patient with polymyositis. Eur J Ophthalmol 16:318–325. https://doi.org/10.1177/112067210601600220 - DOI - PubMed
    1. Matsuo T, Matsuura S, Nakagawa H (2000) Retinopathy in a patient with thrombotic thrombocytopenic purpura complicated by polymyositis. Jpn J Ophthalmol 44:161–164. https://doi.org/10.1016/s0021-5155(99)00187-2 - DOI - PubMed

LinkOut - more resources